Document is current
Any future updates will be listed below
-
Authors
Cater, Rosemary J.
Chua, Geok Lin
Erramilli, Satchal K. http://orcid.org/0000-0001-8694-7681
Keener, James E.
Choy, Brendon C. http://orcid.org/0000-0001-7070-073X
Tokarz, Piotr
Chin, Cheen Fei http://orcid.org/0000-0001-6753-9228
Quek, Debra Q. Y.
Kloss, Brian http://orcid.org/0000-0003-0130-8739
Pepe, Joseph G. http://orcid.org/0000-0003-2993-1872
Parisi, Giacomo
Wong, Bernice H. http://orcid.org/0000-0001-8981-1376
Clarke, Oliver B. http://orcid.org/0000-0003-1876-196X
Marty, Michael T. http://orcid.org/0000-0001-8115-1772
Kossiakoff, Anthony A.
Khelashvili, George http://orcid.org/0000-0001-7235-8579
Silver, David L. http://orcid.org/0000-0002-7289-9890
Mancia, Filippo http://orcid.org/0000-0003-3293-2200
- License Information
-
More Information
Article History
Received: 7 February 2021
Accepted: 17 May 2021
First Online: 16 June 2021
Competing interests
: D.L.S. is a scientific founder and advisor of Travecta Therapeutics that has developed a drug delivery platform that uses MFSD2A transport. All other authors declare no competing interests.
